The introduction of off-brand imatinib represents a significant opportunity for patients battling chronic myeloid leukemia and other illnesses. Original brand-name imatinib, branded as Gleevec, carries a considerable https://careprost655945.xzblogs.com/83964114/off-brand-gleevec-a-cost-effective-option